Paggiarino Dario A.
EyePoint Pharmaceuticals, Inc. · Chief Medical Officer
Dario A. Paggiarino serves as the Chief Medical Officer at EyePoint Pharmaceuticals, Inc., a company specializing in innovative treatments for eye diseases. His recent trading activities include multiple sales of company shares, with a total of 27 disclosures recorded from January 25, 2024, to April 2, 2024. Notably, the largest transaction involved a sale valued at approximately $867.7K on January 30, 2024, reflecting a focused approach to his investments in the healthcare sector.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $7.5k300 shares | SellJan 25, 2024 | $25.00 | $13.04 | |
| $141k5.7k shares | SellJan 24, 2024 | $25.02 | $13.04 | |
| $140k5.6k shares | SellJan 24, 2024 | $25.01 | $13.04 | |
| $77k3.1k shares | SellJan 23, 2024 | $25.00 | $13.04 | |
| $51k2k shares | SellJan 23, 2024 | $25.00 | $13.04 |